Effects of single-agent bortezomib as post-transplant consolidation therapy on multiple myeloma-related bone disease: a randomized phase II study.
about
Effects of single-agent bortezomib as post-transplant consolidation therapy on multiple myeloma-related bone disease: a randomized phase II study.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Effects of single-agent bortez ...... : a randomized phase II study.
@en
Effects of single-agent bortez ...... : a randomized phase II study.
@nl
type
label
Effects of single-agent bortez ...... : a randomized phase II study.
@en
Effects of single-agent bortez ...... : a randomized phase II study.
@nl
prefLabel
Effects of single-agent bortez ...... : a randomized phase II study.
@en
Effects of single-agent bortez ...... : a randomized phase II study.
@nl
P2093
P2860
P50
P356
P1476
Effects of single-agent bortez ...... e: a randomized phase II study
@en
P2093
Alois Lang
Anna Potamianou
Ayşen Timurağaoğlu
Caroline Feys
Catherine Couturier
Evangelos Terpos
Gabriele Armbrecht
Gülsan Sucak
Johannes Drach
John A Snowden
P2860
P356
10.1111/BJH.14637
P407
P577
2017-04-06T00:00:00Z